Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julius Popp

Showing results (51-60 of 156) with videos related to

Pageof 16
Sort By:
Journal of Alzheimer'S Disease : JAD|June 20, 2012
Dimethylarginines, homocysteine metabolism, and cerebrospinal fluid markers for Alzheimer's diseaseSönke Arlt, Edzard Schwedhelm, Heike Kölsch, et al.
Alzheimer'S Research & Therapy|March 26, 2021
Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progressionChristopher Clark, Piotr Lewczuk, Johannes Kornhuber, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 28, 2017
Neuroticism, depression, and anxiety traits exacerbate the state of cognitive impairment and hippocampal vulnerability to Alzheimer's diseaseValérie Zufferey, Alessia Donati, Julius Popp, et al.
Journal of Alzheimer'S Disease : JAD|August 8, 2009
Homocysteine metabolism and cerebrospinal fluid markers for Alzheimer's diseaseJulius Popp, Piotr Lewczuk, Michael Linnebank, et al.
Clinical Chemistry and Laboratory Medicine|September 11, 2012
Determinants of the essential one-carbon metabolism metabolites, homocysteine, S-adenosylmethionine, S-adenosylhomocysteine and folate, in cerebrospinal fluidDesirée E C Smith, Yvo M Smulders, Henk J Blom, et al.
Journal of Cellular and Molecular Medicine|April 21, 2009
RXRA gene variations influence Alzheimer's disease risk and cholesterol metabolismHeike Kölsch, Dieter Lütjohann, Frank Jessen, et al.
Analytica Chimica Acta|October 8, 2018
A global HILIC-MS approach to measure polar human cerebrospinal fluid metabolome: Exploring gender-associated variation in a cohort of elderly cognitively healthy subjectsHéctor Gallart-Ayala, Ioana Konz, Florence Mehl, et al.
Data in Brief|November 21, 2018
LC-HRMS data as a result of untargeted metabolomic profiling of human cerebrospinal fluidFlorence Mehl, Héctor Gallart-Ayala, Ioana Konz, et al.
Iscience|February 8, 2024
Cholesterol-metabolism, plant sterols, and long-term cognitive decline in older people - Effects of sex and APOEe4Matteo Spinedi, Christopher Clark, Leonardo Zullo, et al.
Swiss Medical Weekly|December 5, 2020
Conference report: dementia research and care and its impact in SwitzerlandThomas Leyhe, Mathias Jucker, Tobias Nef, et al.
Pageof 16

Showing results (51-60 of 156) with videos related to

Sort By:
Pageof 16
Journal of Alzheimer'S Disease : JAD|June 20, 2012
Dimethylarginines, homocysteine metabolism, and cerebrospinal fluid markers for Alzheimer's diseaseSönke Arlt, Edzard Schwedhelm, Heike Kölsch, et al.
Alzheimer'S Research & Therapy|March 26, 2021
Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progressionChristopher Clark, Piotr Lewczuk, Johannes Kornhuber, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 28, 2017
Neuroticism, depression, and anxiety traits exacerbate the state of cognitive impairment and hippocampal vulnerability to Alzheimer's diseaseValérie Zufferey, Alessia Donati, Julius Popp, et al.
Journal of Alzheimer'S Disease : JAD|August 8, 2009
Homocysteine metabolism and cerebrospinal fluid markers for Alzheimer's diseaseJulius Popp, Piotr Lewczuk, Michael Linnebank, et al.
Clinical Chemistry and Laboratory Medicine|September 11, 2012
Determinants of the essential one-carbon metabolism metabolites, homocysteine, S-adenosylmethionine, S-adenosylhomocysteine and folate, in cerebrospinal fluidDesirée E C Smith, Yvo M Smulders, Henk J Blom, et al.
Journal of Cellular and Molecular Medicine|April 21, 2009
RXRA gene variations influence Alzheimer's disease risk and cholesterol metabolismHeike Kölsch, Dieter Lütjohann, Frank Jessen, et al.
Analytica Chimica Acta|October 8, 2018
A global HILIC-MS approach to measure polar human cerebrospinal fluid metabolome: Exploring gender-associated variation in a cohort of elderly cognitively healthy subjectsHéctor Gallart-Ayala, Ioana Konz, Florence Mehl, et al.
Data in Brief|November 21, 2018
LC-HRMS data as a result of untargeted metabolomic profiling of human cerebrospinal fluidFlorence Mehl, Héctor Gallart-Ayala, Ioana Konz, et al.
Iscience|February 8, 2024
Cholesterol-metabolism, plant sterols, and long-term cognitive decline in older people - Effects of sex and APOEe4Matteo Spinedi, Christopher Clark, Leonardo Zullo, et al.
Swiss Medical Weekly|December 5, 2020
Conference report: dementia research and care and its impact in SwitzerlandThomas Leyhe, Mathias Jucker, Tobias Nef, et al.
Pageof 16